cms_NM: 88

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
88 RIO RANCHO CENTER 325033 4210 SABANA GRANDE SE RIO RANCHO NM 87124 2018-02-12 756 F 0 1 M2BO11 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and interview, the facility failed to develop a policy/procedure for the monthly drug regimen review that included time frames for the different steps in the process and failed to ensure that consultant pharmacist recommendations were forwarded to the physician for review. These deficient practices have the potential to affect all 113 residents identified on the alphabetical census list provided by the Administrator on 02/05/18. If consultant pharmacist recommendations are not being reviewed by the physician, residents are likely to experience a potential for unnecessary drug interactions and adverse side effects. The findings are: [NAME] Record review of R #101's pharmacist recommendation dated 03/31/17 stated, (R #101) receives [MEDICATION NAME] (Medication that treats [MEDICAL CONDITION] and [MEDICAL CONDITION] disorder) 125 mg (milligrams) TID (three times a day) for dementia with associated behaviors. Please consider a gradual dose reduction, perhaps decreasing to [MEDICATION NAME] 125 mg BID (twice a day) . The recommendation was signed by the Director of Nursing (DON) on 04/15/17. There was no response from the physician noted. B. Record review of R #101's pharmacist recommendation dated 04/26/17 stated (R #101) receives [MEDICATION NAME] (an antipsychotic medication) 50 mg BID (twice a day) . Please consider a gradual dosage reduction to [MEDICATION NAME] 25 mg QAM (every morning) and 50 mg at HS (at bedtime), with the end goal of discontinuations of therapy. The recommendation was signed by the DON on 05/15/17. There was no response from the physician noted. C. On 02/08/18 at 11:41 am, during an interview with the DON, she stated that when she signs the recommendation it indicates that she has received it from the pharmacist and reviewed it herself. She stated she usually reviews the recommendations with the physician in person. She stated that after looking for R #101's recommendation dated 03/31/17 and 04/26/17, she could not find anything that showed the physician was aware of them. She stated she does not know if the physician was made aware of the recommendation in another way. D. Record review of the facility's current policy on Medication Regimen Review dated 11/28/16 revealed there are no time frames given for the different steps of the medication regimen review. E. On 02/08/18 at 9:46 am, during an interview with the Administrator, he verified their policy does not specify specific timeframe's given for the different steps of the medication regimen review process. He stated they are working on formulating a new policy to include timeframe's. 2020-09-01